Thermo Fisher Scientific Inc. ($TMO) reported its fourth-quarter earnings for fiscal year 2024, revealing an adjusted earnings per share (EPS) of $6.10, surpassing estimates of $5.94. The company's revenue reached $11.4 billion, exceeding expectations of $11.29 billion and reflecting a year-over-year increase of 4.68%. Net income for the quarter was reported at $1.83 billion. The growth in Q4 was attributed to strong demand for its tools and services, driven by new product launches and strategic acquisitions. For fiscal year 2025, Thermo Fisher provided guidance of 3% to 4% organic revenue growth, despite facing 1.5% foreign exchange headwinds. The company anticipates flat growth in the first quarter compared to its competitor Danaher Corp., which is projected to experience low single-digit declines.